Which conditions are associated with increased risk of vascular calcifications due to mineral bone disorder?

• A. Osteoporosis with vertebral compression
• B. CKD-MBD; secondary or tertiary hyperparathyroidism; use of calcium-based phosphate binders
• C. Hypervitaminosis D with hypercalcemia
• D. Paget disease of bone

Answer: (B)

Vascular calcifications in mineral bone disorder are driven by disruptions in calcium and phosphate handling that occur in chronic kidney disease. When kidneys fail to excrete phosphate effectively, serum phosphate rises and, together with reduced active vitamin D, triggers secondary hyperparathyroidism. The resulting rise in parathyroid hormone drives bone turnover and mobilizes calcium, and the combination can push the calcium-phosphate product toward precipitation in vascular walls. Adding to this, calcium-based phosphate binders used to treat hyperphosphatemia increase the calcium load, further elevating the calcium-phosphate product and promoting vascular calcification. This combination—CKD-MBD with secondary or tertiary hyperparathyroidism and use of calcium-containing phosphate binders—explains the increased risk.

Other listed conditions don’t fit this specific mechanism. Osteoporosis with vertebral compression centers on bone fragility, not on systemic mineral disturbances driving vascular calcification. Paget disease involves abnormal bone remodeling but not the mineral disorder that promotes vessel calcification. Hypervitaminosis D can cause hypercalcemia, but it’s not the same CKD-specific pathway linking phosphate retention, secondary/tertiary hyperparathyroidism, and calcium-phosphate–mediated vascular calcification.